MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD





MBL
2014.07.18 Anti-2,2,7-trimethylguanosine (m3G/TMG) mAb is now available. For RNA immunoprecipitation, Immunocytochemistry and RNP immunoprecipitation. This antibody specifically reacts with m3G, a modified nucleoside at the 5'-cap site of U snRNAs. [NEW] Quality Control Survey of Autoantibodies
2014.07.18 PCSKp-cIAP1 in vitro Binding Assay Kit is now available. For screening and evaluation of inhibitors of PCSK9-cIAP1 interaction in vitro. [NEW]  
2014.07.18 Anti-Human S100A6 polyclonal antibody is now available. S100A6 is involved in cell cycle regulation and exocytosis and in the regulation of heat shock proteins and cytoskeletal dynamics. Overexpression of S100A6 has been observed in patients suffering from Alzheimer disease or ALS. [NEW]  
2014.07.08 Anti-Human Syntaxin-17 monoclonal antibody is now launched. For Western blotting, Immunoprecipiration and Immunocytochemistry. Syntaxin-17 is one of new key players in Autophagy.  
2014.07.08 Anti-Strep-tag II monoclonal antibody is now available. Useful for Western blotting, Immunoprecipitation and Immunocytochemistry.  
 
2014.06.19 CE Mark of a novel reagent to detect RAS (KRAS and NRAS) gene mutations for testing of anti-EGFR therapeutic antibodies to colon cancer prior to treatment.
PDF: 59KB
2014.06.10 MBL International Corporation opens a new R&D laboratory. PDF: 39KB
2012.12.04 MHC tetramer reagents and infectious disease, cancer antigen epitope identification reagents: worldwide business transfer for development, manufacturing and distribution
2011.06.20 China National Biotec Group and Medical & Biological Laboratories Co., Ltd. have agreed to a Comprehensive Business Alliance Establishment of Business Operations for Clinical Diagnostic Business and Therapeutic Monoclonal Antibody Development in China
 

 

copyright